Nissan Medical Industries Ltd

TASE:NISA Stock Report

Market Cap: ₪138.7m

Nissan Medical Industries Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Hezi Nissan

Chief executive officer

₪2.0m

Total compensation

CEO salary percentage28.9%
CEO tenure41.4yrs
CEO ownershipn/a
Management average tenure16.3yrs
Board average tenure12.4yrs

Recent management updates

What Can We Conclude About Nissan Medical Industries' (TLV:NISA) CEO Pay?

Dec 11
What Can We Conclude About Nissan Medical Industries' (TLV:NISA) CEO Pay?

Recent updates

We Think Nissan Medical Industries' (TLV:NISA) Profit Is Only A Baseline For What They Can Achieve

Mar 27
We Think Nissan Medical Industries' (TLV:NISA) Profit Is Only A Baseline For What They Can Achieve

Nissan Medical Industries (TLV:NISA) Has A Somewhat Strained Balance Sheet

Mar 18
Nissan Medical Industries (TLV:NISA) Has A Somewhat Strained Balance Sheet

Nissan Medical Industries (TLV:NISA) Will Be Hoping To Turn Its Returns On Capital Around

Nov 30
Nissan Medical Industries (TLV:NISA) Will Be Hoping To Turn Its Returns On Capital Around

Calculating The Intrinsic Value Of Nissan Medical Industries Ltd (TLV:NISA)

Oct 26
Calculating The Intrinsic Value Of Nissan Medical Industries Ltd (TLV:NISA)

Calculating The Intrinsic Value Of Nissan Medical Industries Ltd (TLV:NISA)

Dec 14
Calculating The Intrinsic Value Of Nissan Medical Industries Ltd (TLV:NISA)

Is Nissan Medical Industries (TLV:NISA) Using Too Much Debt?

Nov 09
Is Nissan Medical Industries (TLV:NISA) Using Too Much Debt?

Is Nissan Medical Industries (TLV:NISA) Using Too Much Debt?

Jan 03
Is Nissan Medical Industries (TLV:NISA) Using Too Much Debt?

Do Nissan Medical Industries's (TLV:NISA) Earnings Warrant Your Attention?

May 07
Do Nissan Medical Industries's (TLV:NISA) Earnings Warrant Your Attention?

Under The Bonnet, Nissan Medical Industries' (TLV:NISA) Returns Look Impressive

Apr 14
Under The Bonnet, Nissan Medical Industries' (TLV:NISA) Returns Look Impressive

Does Nissan Medical Industries (TLV:NISA) Have A Healthy Balance Sheet?

Mar 27
Does Nissan Medical Industries (TLV:NISA) Have A Healthy Balance Sheet?

Nissan Medical Industries (TLV:NISA) Shareholders Have Enjoyed An Impressive 227% Share Price Gain

Mar 09
Nissan Medical Industries (TLV:NISA) Shareholders Have Enjoyed An Impressive 227% Share Price Gain

Is Nissan Medical Industries Ltd.'s (TLV:NISA) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 18
Is Nissan Medical Industries Ltd.'s (TLV:NISA) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Does Nissan Medical Industries (TLV:NISA) Deserve A Spot On Your Watchlist?

Feb 01
Does Nissan Medical Industries (TLV:NISA) Deserve A Spot On Your Watchlist?

Should We Be Excited About The Trends Of Returns At Nissan Medical Industries (TLV:NISA)?

Jan 13
Should We Be Excited About The Trends Of Returns At Nissan Medical Industries (TLV:NISA)?

Is Nissan Medical Industries (TLV:NISA) Using Too Much Debt?

Dec 26
Is Nissan Medical Industries (TLV:NISA) Using Too Much Debt?

What Can We Conclude About Nissan Medical Industries' (TLV:NISA) CEO Pay?

Dec 11
What Can We Conclude About Nissan Medical Industries' (TLV:NISA) CEO Pay?

Introducing Nissan Medical Industries (TLV:NISA), A Stock That Climbed 89% In The Last Year

Nov 25
Introducing Nissan Medical Industries (TLV:NISA), A Stock That Climbed 89% In The Last Year

CEO Compensation Analysis

How has Hezi Nissan's remuneration changed compared to Nissan Medical Industries's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

₪18m

Dec 31 2023n/an/a

₪6m

Sep 30 2023n/an/a

-₪9m

Jun 30 2023n/an/a

-₪35m

Mar 31 2023n/an/a

-₪38m

Dec 31 2022₪2m₪579k

-₪36m

Sep 30 2022n/an/a

-₪24m

Jun 30 2022n/an/a

-₪483k

Mar 31 2022n/an/a

₪16m

Dec 31 2021₪2m₪561k

₪36m

Sep 30 2021n/an/a

₪49m

Jun 30 2021n/an/a

₪66m

Mar 31 2021n/an/a

₪67m

Dec 31 2020₪3m₪561k

₪57m

Sep 30 2020n/an/a

₪42m

Jun 30 2020n/an/a

₪30m

Mar 31 2020n/an/a

₪13m

Dec 31 2019₪2m₪593k

₪16m

Sep 30 2019n/an/a

₪22m

Jun 30 2019n/an/a

₪24m

Mar 31 2019n/an/a

₪32m

Dec 31 2018₪3m₪575k

₪25m

Sep 30 2018n/an/a

₪27m

Jun 30 2018n/an/a

₪24m

Mar 31 2018n/an/a

₪16m

Dec 31 2017₪3m₪1m

₪13m

Compensation vs Market: Hezi's total compensation ($USD530.00K) is about average for companies of similar size in the IL market ($USD432.00K).

Compensation vs Earnings: Hezi's compensation has been consistent with company performance over the past year.


CEO

Hezi Nissan (67 yo)

41.4yrs

Tenure

₪2,001,000

Compensation

Mr. Yeheskel Nissan, also known as Hezi, has been the Chief Executive Officer at Nissan Medical Industries Ltd. since 1983 and serves as its Director 1996 and serves as its Managing Director. Mr. Nissan se...


Leadership Team

NamePositionTenureCompensationOwnership
Yeheskel Nissan
CEO, MD & Director41.4yrs₪2.00mno data
Michael Schwartzman
Company Technologistno data₪840.00kno data
Arnon Tuval
Vice President of Global Marketing & Salesno data₪842.00kno data
Ron Broshi
Vice President of Business Development & Products at Sfantak16.3yrs₪868.00kno data
Ron Bahat
Manager of the Subsidiary Production Siteno data₪886.00kno data
Moshe Zorea
Chief Financial Officer2yrs₪829.00kno data

16.3yrs

Average Tenure

65yo

Average Age

Experienced Management: NISA's management team is seasoned and experienced (16.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yeheskel Nissan
CEO, MD & Director28.4yrs₪2.00mno data
Yael Git
Independent Director12.4yrsno datano data
Abraham Harel
Chairman of the Board21.4yrsno datano data
Esther Levy
Independent Director9.4yrsno datano data
Boaz Nagar
Independent Director9.4yrsno datano data

12.4yrs

Average Tenure

65yo

Average Age

Experienced Board: NISA's board of directors are seasoned and experienced ( 12.4 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.